Registrars: | Capita Registrars |
CFO: | Gerald Desler |
Chief Executive Officer : | Mark Eccleston |
Executive Director: | Tralau Stewart |
Non-Executive Chairman: | Martin Gouldstone |
Non-Executive Dir: | Cathy Tralau-Stewart |
Address: | Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD |
Website: | http://www.valirx.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BLH13C52 |
Currency | UK Pounds |
Share Price | 0.55p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.15 |
52 Week Low | 0.42 |
Volume | 479,222 |
Shares Issued | 374.35m |
Market Cap | £2.06m |
RiskGrade | 435 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
10:14 | 6,427 @ 0.56p |
10:01 | 400,000 @ 0.50p |
09:55 | 4,564 @ 0.57p |
08:50 | 16,966 @ 0.57p |
08:14 | 51,265 @ 0.51p |
You are here: research